Lupin gets US FDA approval for generic Edecrin tablets to treat edema

Lupin gets US FDA approval for generic Edecrin tablets to treat edema

By, Admin 10 September 2019

Pharma major Lupin Limited announced that it has received United States Food and Drug Administration (FDA) approval for its ethacrynic acid tablets USP, 25 mg. Lupin’s ethacrynic acid tablets USP, 25 mg, is the generic version of Edecrin tablets, 25mg, of Bausch Health Americas, Inc. It is indicated for treatment of edema, when an agent with greater diuretic potential than those commonly employed is required. It is also indicated for the treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, short-term management of ascites due to malignancy, idiopathic edema, and lymphedema, short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome and Intravenous ethacrynic acid sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. Ethacrynic acid tablets USP had annual sales of approximately USD 24 million in the US (IQVIA MAT June 2019).

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!